InvestorsHub Logo
Followers 11
Posts 402
Boards Moderated 0
Alias Born 09/01/2021

Re: Kydg post# 5749

Friday, 01/12/2024 2:21:26 PM

Friday, January 12, 2024 2:21:26 PM

Post# of 7828
08 Nov 2023Revance Therapeutics expects approval of daxibotulinumtoxin A in China for the treatment of Glabellar lines in 2024
08 Nov 2023Revance Therapeutics expects approval of daxibotulinumtoxin A in China for the treatment of Torticollis in 2024
08 Nov 2023Revance Therapeutics intends to receive a permanent J-Code for daxibotulinumtoxin A for the treatment of Torticollis in early 2024
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News